Phase 1 trial for treatment of COVID‐19 patients with pulmonary fibrosis using hESC‐IMRCs

Detalles Bibliográficos
Autores principales: Wu, Jun, Zhou, Xing, Tan, Yuanqing, Wang, Liu, Li, Tianda, Li, Zhongwen, Gao, Tingting, Fan, Jiaqi, Guo, Baojie, Li, Wei, Hao, Jie, Wang, Xianguang, Hu, Baoyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645925/
https://www.ncbi.nlm.nih.gov/pubmed/33107132
http://dx.doi.org/10.1111/cpr.12944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645925/
https://www.ncbi.nlm.nih.gov/pubmed/33107132
http://dx.doi.org/10.1111/cpr.12944

Ejemplares similares